Miles Capital Inc. cut its stake in UnitedHealth Group Inc (NYSE:UNH) by 28.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,329 shares of the healthcare conglomerate’s stock after selling 906 shares during the period. Miles Capital Inc.’s holdings in UnitedHealth Group were worth $685,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of UNH. Selective Wealth Management Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth $27,000. North Star Investment Management Corp. acquired a new position in UnitedHealth Group during the third quarter worth about $30,000. Delta Asset Management LLC TN raised its position in UnitedHealth Group by 111.0% in the third quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 81 shares in the last quarter. Fusion Family Wealth LLC raised its position in UnitedHealth Group by 329.7% in the third quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 122 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC raised its position in UnitedHealth Group by 212.5% in the third quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after acquiring an additional 119 shares in the last quarter. Institutional investors own 85.79% of the company’s stock.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. 0.82% of the stock is currently owned by insiders.
Several equities analysts have recently issued reports on UNH shares. Argus reaffirmed a “buy” rating and issued a $340.00 price objective on shares of UnitedHealth Group in a research note on Thursday, December 19th. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $276.00 to $361.00 and gave the stock an “overweight” rating in a report on Friday, December 20th. Credit Suisse Group increased their target price on shares of UnitedHealth Group from $320.00 to $330.00 and gave the company an “outperform” rating in a research note on Wednesday, January 8th. ValuEngine upgraded shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, Morgan Stanley restated a “buy” rating and issued a $312.00 price target (up previously from $294.00) on shares of UnitedHealth Group in a research report on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $313.50.
Shares of UNH stock traded up $1.13 during trading on Tuesday, reaching $299.60. The company had a trading volume of 1,075,724 shares, compared to its average volume of 2,808,256. The firm’s 50 day simple moving average is $290.32 and its two-hundred day simple moving average is $256.42. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $300.99. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.70. The company has a market capitalization of $282.77 billion, a PE ratio of 20.91, a PEG ratio of 1.46 and a beta of 0.65.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.77 by $0.13. UnitedHealth Group had a return on equity of 25.55% and a net margin of 5.71%. The firm had revenue of $60.90 billion during the quarter, compared to analysts’ expectations of $61.17 billion. During the same quarter in the prior year, the business earned $3.28 earnings per share. The company’s revenue was up 4.3% on a year-over-year basis. Analysts forecast that UnitedHealth Group Inc will post 16.47 earnings per share for the current year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Dividend Aristocrat Index
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.